Drug Approval | September 10, 2025
FDA prohibits Sun Pharma's Halol Plant from exporting drugs to US
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
This PSD-3, the first pharmaceutical spray dryer built by GEA for OEB-5 products, sets new standards for high-containment pharmaceutical spray drying
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The company received one observation in the Form-483
Subscribe To Our Newsletter & Stay Updated
